Large-scale population study of human cell lines indicates that dosage compensation is virtually complete
2008

Study on Dosage Compensation in Human Cell Lines

Sample size: 210 publication 10 minutes Evidence: high

Author Information

Author(s): Colette M Johnston, Frances L Lovell, Daniel A Leongamornlert, Barbara E Stranger, Emmanouil T Dermitzakis, Mark T Ross

Primary Institution: Wellcome Trust Sanger Institute

Hypothesis

How does escape from X chromosome inactivation affect dosage compensation in human cell lines?

Conclusion

Dosage compensation in human lymphoblastoid cell lines is virtually complete, with only a small proportion of X-linked genes escaping inactivation.

Supporting Evidence

  • Overall expression from the X chromosome is only slightly higher in females.
  • Only 5.4% of X-linked genes showed significantly higher expression in females.
  • Dosage compensation is achieved effectively in human lymphoblastoid cell lines.

Takeaway

This study looked at how genes on the X chromosome are expressed in males and females. It found that the differences are very small, meaning that both sexes have similar levels of gene activity.

Methodology

Gene expression was analyzed using microarrays from lymphoblastoid cell lines of 210 individuals across four populations.

Potential Biases

Potential for inter-individual variability in gene expression that could affect results.

Limitations

The study focused only on lymphoblastoid cell lines, which may not represent other tissues.

Participant Demographics

210 unrelated individuals from four populations: CEU, CHB, JPT, and YRI.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pgen.0040009

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication